Management of malignant pleural effusion associated with trapped lung syndrome
Qureshi, R. A.
Collinson, S. L.
Powell, R. J.
Froeschle, P. O.
Berrisford, R. G.
JournalAsian cardiovascular and thoracic annals
RightsCopyright © 2008, © SAGE Publications
MetadataShow full item record
Management of recurrent malignant pleural effusion associated with trapped lung syndrome remains problematic. An alternative treatment using a pleural catheter has been advocated. Between August 1999 and August 2002, 127 patients underwent thoracoscopy for malignant pleural effusion. Of these, 52 (41%) with trapped lung were managed by insertion of a pleural catheter. Mean age was 66 years (range, 42-89 years). The most frequent diagnosis was breast cancer. Spontaneous pleurodesis (drainage < 10 mL) occurred in 25 (48%) patients whose catheter was removed after 30 to 255 days (mean, 93.8 days). Symptomatic relief was achieved in 49 (94%) patients. Mean dyspnea score improved significantly from 3.0 to 1.9. Complications comprised catheter blockage, surgical emphysema, cellulitis, and loculated effusion in 2 patients each. Mean length of hospital stay was 3 days (range, 1-16 days). Median survival was 126 days (range, 10-175 days). We conclude that long-term placement of a pleural catheter provides effective palliation for malignant pleural effusion associated with trapped lung syndrome.
Showing items related by title, author, creator and subject.
The NCS-LSD cohort study: a description of the methods and analyses used to assess the long-term effectiveness of enzyme replacement therapy and substrate reduction therapy in patients with lysosomal storage disorders. Henley, W. E.; Anderson, L. J.; Wyatt, K. M.; Nikolaou, V.; Anderson, R.; Logan, Stuart (Springer, 2014-11)Lysosomal storage disorders (LSDs) comprise more than 50 extremely rare, inherited metabolic diseases resulting from a deficiency of specific lysosomal enzymes required for normal macromolecular metabolism. The National ...
Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical Trial. Clarke, Carl E; Patel, Smitaa; Ives, Natalie; Rick, Caroline E; Dowling, Francis; Woolley, Rebecca; Wheatley, Keith; Walker, Marion F; Sackley, Catherine M; PD REHAB Collaborative Group incl:; Butler, Lisa; Elliott, Ruth; Havlin, Fiona; Harrower, Timothy; Holman, Jane; Irvine, Sarah; James, Rob; Lane, Robert; Malone, Timothy; Matthews, Victoria; Pearce, Vaughan R; Potter, Alison; Sheridan, Ray; Smith, Christopher; Woodger, Alan (JAMA, 2016-01-19)It is unclear whether physiotherapy and occupational therapy are clinically effective and cost-effective in Parkinson disease (PD).
Extracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up. Taylor, James M.; Dunkerley, Sarah; Silver, David A.; Redfern, Andrew; Talbot, Nick J.; Sharpe, Ian T.; Guyver, Paul M. (Elsevier, 2016-03)Achilles tendinopathy (AT) represents a triad of tendon pain, swelling and impaired performance. Extracorporeal shockwave therapy (ESWT) has been endorsed by the National Institute for Health and Care Excellence (NICE) for ...